2 days ago
GLP-1 Friendly Food Label Sparks Debate Over Diet Culture
Eatfit Lab is a food business that sells meals through Zomato.
It called some meals “GLP-1 friendly and high protein.”
GLP-1 medicines can make people feel full sooner and eat less.
Because of this, some people taking them may need to focus on protein, fibre, vitamins, minerals and water.
Smaller meals may also help people who experience nausea or other stomach problems.
The foods on the menu are ordinary nutritious foods that can be useful for anyone.
Some people think the label is practical for customers using these medicines.
Others worry that it connects medicine with pressure to be thin, especially for young people.
Eatfit Lab, a cloud kitchen listed on Zomato, advertised food as “GLP-1 friendly and high protein.”
Influencer Shreeum Rakheja criticized the branding, saying it could reinforce pressure to achieve thinness, especially among young people.
The menu includes protein- and nutrient-rich dishes such as vegetable pizza, quinoa salad, chickpeas, spinach and seeds.
People taking GLP-1 medicines may benefit from smaller, nutrient-dense meals because the drugs can reduce appetite and slow digestion.
Experts cited in the article say “GLP-1 friendly” is not a medical certification or evidence that a dish is automatically healthier.
- Who
- Eatfit Lab, influencer Shreeum Rakheja, people taking GLP-1 medicines and online commenters.
- What
- A Zomato-listed cloud kitchen’s “GLP-1 friendly and high protein” marketing prompted debate over nutrition and diet culture.
- Where
- On Zomato and across social media.
- When
- The discussion gained traction after Shreeum Rakheja shared a video questioning the branding.
- Why
- The label may help customers identify smaller, nutrient-dense meals, but critics say using a prescription drug’s name could reinforce thinness-focused diet culture.
Practical nutrition
Diet-culture concerns
Using GLP-1 in food marketing
Practical nutrition
Supporters say the label can help people taking GLP-1 medicines find meals that are relatively small and rich in protein and fibre.
Diet-culture concerns
Critics question why a prescription drug’s name is being used to market restaurant food and worry about the message it sends.
Need for specialised meals
Practical nutrition
People taking GLP-1 medicines may eat less and experience nausea, so smaller, nutrient-dense meals could help them meet nutritional needs.
Diet-culture concerns
The article says there is no medically prescribed branded “GLP-1 diet”; the same foods can be part of a balanced diet for anyone.
Impact on young people
Practical nutrition
Restaurants may be responding to a dietary concern among a growing group of customers using GLP-1 medicines.
Diet-culture concerns
Shreeum Rakheja and other critics fear the branding could connect medication with appearance and intensify thinness pressure among young people.
Key facts
- Business
- Eatfit Lab is a cloud kitchen listed on Zomato.
- Marketing claim
- The business advertised food as “GLP-1 friendly and high protein.”
- Example dish
- Its menu includes a “Women Wellness Estro Green High Protein Powerhouse Pizza.”
- Another dish
- The “Brain Fuel Antioxidant Leafy Green Salad” contains quinoa, boiled chickpeas, pomegranate, parsley and bean sprouts.
- Medication effects
- GLP-1 receptor agonists can reduce appetite and slow the movement of food through the stomach.
- Nutrition guidance
- The Obesity Medicine Association recommends nutrient-dense foods, with attention to protein, fibre and hydration, for people taking GLP-1 medication.
- Label limitation
- “GLP-1 friendly” is not a medical certification and does not automatically mean a dish is healthier.
Quotes
Shreeum Rakheja
Influencer who questioned Eatfit Lab’s use of GLP-1 branding
““I was looking for a sandwich on Zomato, and I came across this. GLP-1 friendly and high protein food. A medicine's name is in the title of a restaurant, and we are OK with this. Imagine growing up, being 14, 15, 16 as a girl... and imagine reading this.””
livemint.com
““This culture of thinness bothers me.””
livemint.com
Sources
Related news
Nestle targets weight-loss drug users with AI-driven new products
Expert Questions Whether GLP-1 Drugs Are Creating New Diet Culture
China’s Weight-Loss Drug Market Attracts Big Pharma Advertising Push
Serena Williams Defends GLP-1 Weight-Loss Drug Use; Doctors Urge Caution
Karan Johar Explains Weight Loss Amid Ozempic Rumours
India-Brazil Friendly Tickets Sell Out Amid Kolkata Football Fever
Sumadhura Group Plans ₹2,000 Crore Industrial Logistics Expansion
Bengaluru Man Says Zomato Pav Bhaji Came With Smoked Beedi
Zomato Bans Analogue Paneer Over Transparency Concerns
FSSAI Crackdown Could Expand India’s Organised Paneer Market
